We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

New draft guidance for Alzheimer’s treatments

17 February 2016

Focus on Regulation – Hogan Lovells Blog
On 1 February 2016, the European Medicines Agency (“EMA”) launched a public consultation concerning a “Draft guideline on the clinical investigation of medicines for the treatment of Alzheimer’s disease and other dementias“.To read more click here

The team

Loading data